 |
| TRTC and BMIX Look Finish Strong This Week |
|
 Hot Stock to Watch
|
Company: Brazil Minerals Inc. (OTCQB: BMIX)
|
End of Day:
Price: 0.055
Change (%): + 0.0055 (11.11)
Volume: 28,100 |
 |
Brazil Minerals, Inc. Receives GIA Grading for Mined Fancy Colored Diamond
BELO HORIZONTE, BRAZIL-(Marketwired - Sep 24, 2014) - Brazil Minerals, Inc. (OTCQB: BMIX), (the “Company” or “BMIX”), a U.S. holding company with revenues from sales of gold and diamonds, announced today that one of the diamonds produced by Mineração Duas Barras Ltda. (“MDB”) was graded as a fancy color diamond by the Gemological Institute of America (“GIA”).
Fancy colored diamonds are much rarer than the usual colorless gems that MDB produces. Colored diamonds lend themselves well to specific jewelry pieces, which may command a price substantially higher than a sale of the polished diamond. BMIX is studying the Brazilian colored diamond market because of the high margins that it can produce and the fact that it is complementary and synergistic to its current colorless diamond business. The colors most commonly seen in Brazilian fancy diamonds are yellow, pink, and blue.
Continue Reading
|
 Yesterday's Top Performer
|
Company: Terra Tech Corp (OTCQB: TRTC)
|
End of Day:
Price: 0.2545
Change (%): + 0.0345 (15.68)
Volume: 1,687,155 |
 |
Inergetics Discovers Unique Combination of Cannabinoids for New Product Line as it Exits Phase II of R&D and Prepares for Final Development Phase
Breakthrough Further Illustrates Inergetics' Position as Nutraceutical Innovator
NEWARK, N.J., Sept. 24, 2014 /PRNewswire/ - Inergetics, Inc. (OTCBB: NRTI), a leading developer of nutritional supplements, today announced that it has identified and procured a non-cannabis source of an important cannabinoid that will be incorporated into its initial “first to market” combination cannabinoid product line to provide additional synergistic benefits in terms of overall efficacy and absorption.
“With direction from our Scientific/Medical Advisory Board and strategic relationships we have developed internationally, Inergetics has sourced and procured a novel non-cannabis cannabinoid to work side-by-side with CBD,” states Chief Science Officer Carl Germano, RD, CNS, CDN. “This additional cannabinoid from a non-cannabis source is a perfect companion to our CBD ingredient as it targets receptors in the body that help control inflammation and pain signaling. By bringing these two important cannabinoids together, our first nutraceutical CBD product line is capable of feeding the body’s own endocannabinoid system while delivering greater efficacy and helping to enhance absorption.”
Continue Reading |
Other Small Cap News
|
Company: Infusion Brands (OTCQB: ASTV)
|
Infusion Brands Wins Top Industry Honor With Ronco's Pocket Fisherman
CLEARWATER, FL--(Marketwired - Sep 26, 2014) - Infusion Brands', (OTCQB: ASTV), Ronco Pocket Fisherman, the original As Seen on TV compact fishing pole, won the 2014 Electronic Retailing Association (ERA) Moxie Award for the Best Short Form Spot, People's Choice. The Moxie Awards are the infomercial industry's version of the Academy Awards, trumpeting the best direct response campaigns of the year. Infusion Brands was selected for this year's People's Choice Award over direct marketers Havas Edge, IdeaVillage, Guthy-Renker, and TaxACT.com.
"We are thrilled to be honored for a product that has been a game changer in the direct response industry for many generations of consumers," said Bob DeCecco, Chairman and CEO of Infusion Brands. "In the fourth quarter of 2014, we will bring the Ronco Pocket Fisherman back to the American television set, as well as internationally with our direct response distribution partners."
Continue Reading
|
Company: Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX)
|
Cannabics Pharmaceuticals, Inc. (CNBX) Attains GMP Compliance, Prepares for First Clinical Study of Cannabics SR
Israel-Based Study Designed to Determine Capsules' Efficacy as a Palliative Therapy for Oncology Patients
BETHESDA, MD--(Marketwired - Sep 26, 2014) - Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX), a developer of advanced medical cannabis therapies, announces that it has achieved Good Manufacturing Practices (GMP) capabilities as the Company moves toward the launch of its first clinical study of Cannabics SR capsules.
GMP regulations are designed to ensure that products are produced and controlled according to quality standards. Adhering to these practices ranks Cannabics' products among a very limited number of medical cannabis products available in the U.S. market that are manufactured according to GMP standards.
Continue Reading |
Market News
|
By Andy Kiersz: Reuters
|
Here's The Best Way To Buy Stocks If You Fear A Market Crash
Investing in the stock market can be extremely frustrating for those who look back on the big rally they missed and nerve-wracking for those who believe the may be putting money into the market at the top.
The S&P 500 has roared almost 200% from its March 9, 2009 low close of 676 to its high of 2,011 on September 18.
With today's big market selloff, some are worrying that we've seen the market peak. This obviously would make investors extremely hesitant to buy stocks for fear of a big decline or perhaps a crash.
Continue Reading
|
By Emelia Sithole-Matarise: Reuters
|
Dollar holds near four-year highs, Europe stocks recover
LONDON (Reuters) - The dollar held just below a four-year high against a basket of currencies on Friday, fuelled by the biggest yield advantage over the euro in nearly 15 years as the Federal Reserve contemplates hiking interest rates.
European equities shrugged off a sharp sell-off in Asian and U.S. markets overnight, clawing off one-month lows and led by euro zone banks, seen as the big winners of the European Central Bank's measures to prop up inflation and kick-start growth.
U.S. stock index futures pointed to a slightly firmer start on Wall Street after Thursday's sharp selloff triggered by Apple Inc and the rallying dollar.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
